Generic and biosimilar medicines: quid?
Once intellectual property protection, data and marketing exclusivity of reference medicines have expired, generic medicines and biosimilar medicines can enter the off-patent market. This market entry is conditional on the approval of marketing authorization, pricing and reimbursement. Given that th...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2012-12-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/448 |